VERTEBRATE ANTIBODIES LIMITED - Key Persons
Job Titles:
- Assistant at Kerbala University
Aqeel Al Jothery is an assistant at Kerbala University. He is also as a Research Fellow at Aberdeen University. Aqeel research interest is focused on the energy balance - the factors that drive food intake, metabolic rate, total energy expenditure, and subsequent life-history patterns such as reproductive performance, oxidative stress, obesity, and aging. Aqeel will market the Company in the Middle East, and provide advice on future links and collaborations.
Bertrand Collet's main area of research is the antiviral innate immune system of salmonid fish and more specifically the role of Interferon Induced Genes (ISGs) in the immunity to viruses and the mechanism of action of antiviral DNA vaccines. He recently designed an efficient approach to generate salmonid knock-out cell lines by CRISPR/Cas9 genome editing in order to elucidate ISGs functions. Bertranad will advise on the development of biotechnological tools for the improvement of fish infectiology and diagnostic methods.
Job Titles:
- Immunologist
- Director of Biologicals
Dr Tiehui Wang is a leading immunologist with a research focus on regulation of fish immune system, immune stimulation, and novel vaccine development. Dr Wang will be the Director of Biologicals at VAL to establish and oversee the development and production of novel recombinants, including immune regulatory cytokines, antimicrobial peptides, immune stimulants such as flagellins, vaccine candidates, and disease biomarkers. Combining the existing knowledge and innovative antibody approach at VAL with the recombinant technology and the novel biologicals created by Dr Wang will provide solutions and reagents long sought by the aquaculture sector to advance research, assist in the development of novel diagnostics, therapeutics and vaccines.
Graeme Murray is Professor of Pathology and academic clinical speciality lead for Pathology at the University of Aberdeen. He is lead consultant gastro-intestinal pathologist to NHS Grampian and clinical lead for the Grampian Biorepository. Professor Murray is an internationally recognised pathologist with specific interests in gastro-intestinal pathology and cancer biomarker discovery whereby he has identified and validated tumour markers, some of which have completed a phase 1 clinical trial. Professor Murray will advise on potential tumour biomarkers and novel cancer pathways as well as assessing the clinical potential of VAL's products.